France is not “another EU country with a translation step.” Pricing, access, promotion, and how you show up locally have their own machinery. Companies that treat market entry as a rollout of the UK or US playbook usually find out the expensive way.
Elliogen is independent strategic advice for market entry and commercial navigation in France. It sits under Matt Powell T/A Elliogen, alongside the software products I build. When the answer is a tool, I ship a tool. When the answer is judgement — sequencing, stakeholders, what not to do — that is advisory work.
What the work actually is
Typical questions:
- Should we enter with an affiliate, a partner, or a lighter presence first?
- What does a credible access and commercial plan look like before we hire a full local team?
- How do we talk about the product without importing claims that will not survive local review?
- Where does software help (monitoring, intelligence, compliance) and where do you still need a person?
I also take technical-build advisory: you have a pharma-ops problem and need someone who has already shipped products in this space, not a generalist consultancy.
A practical starting point: Market entry in France for life-sciences companies.
How this relates to the products
Everything that is not Phormulate currently sits under this trading name: IndicationIQ, RegulatoryAlerts, PromoPack, PostBroadcaster, and HiddenLogo. Advisory is the human counterpart — useful when you need a plan, not a login.